PhoenixBio Co., Ltd. (6190.T)
JPY 325.0
(-0.31%)
JPY 325.0
(-0.31%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 491.35 Million JPY | 128.84% |
| 2022 | 214.71 Million JPY | -78.7% |
| 2021 | 1 Billion JPY | -0.25% |
| 2020 | 1.01 Billion JPY | 0.59% |
| 2019 | 1 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 280 Million JPY | -6.67% |
| 2023 Q4 | 491.35 Million JPY | 53.55% |
| 2023 Q3 | 320 Million JPY | 0.0% |
| 2023 Q1 | - JPY | -100.0% |
| 2023 Q2 | - JPY | 0.0% |
| 2023 FY | 491.35 Million JPY | 128.84% |
| 2022 Q3 | - JPY | -100.0% |
| 2022 Q2 | 900 Million JPY | 0.0% |
| 2022 Q4 | 214.71 Million JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | 35.941% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | 75.432% |
| Linical Co., Ltd. | 1.49 Billion JPY | 67.242% |
| Trans Genic Inc. | 1.32 Billion JPY | 62.975% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -62813.06% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 79.065% |
| AnGes, Inc. | 214.94 Million JPY | -128.59% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -359.855% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 99.223% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | -481.061% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 55.691% |
| Carna Biosciences, Inc. | 28.4 Million JPY | -1629.987% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | 43.884% |
| RaQualia Pharma Inc. | 39.05 Million JPY | -1158.261% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | 73.267% |
| PeptiDream Inc. | 19.63 Billion JPY | 97.498% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | -204.998% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | -23.766% |
| Healios K.K. | 450 Million JPY | -9.189% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | -535.716% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | 36.46% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | 37.646% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| StemCell Institute Inc. | 6.67 Million JPY | -7259.961% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | -241.809% |